Merck Licenses Anti-Tau Alzheimer’s Antibody from Teijin Pharma
Posted on29 May 2017
Comments0
Teijin Pharma granted Merck exclusive global rights to develop, manufacture, and commercialize a preclinical-stage anti-tau antibody. Merck says the antibody candidate will... Read More